{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:37:18Z","timestamp":1777869438780,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["N0.82071435"],"award-info":[{"award-number":["N0.82071435"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.neuroscience.2026.02.023","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:23:52Z","timestamp":1771287832000},"page":"152-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-ASC antibodies alleviate Alzheimer\u2019s disease\u2013type pathology in APP\/PS1 mice"],"prefix":"10.1016","volume":"599","author":[{"given":"Liu","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Xiaopeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deng","family":"Juan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.023_b0005","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00015.2020","article-title":"The complexity of Alzheimer's disease: an evolving puzzle","volume":"101","author":"Ferrari","year":"2021","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.023_b0010","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41398-020-00918-y","article-title":"Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer's disease-type pathology and cognitive deficits in APP\/PS1 mice","volume":"10","author":"Wang","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"10284","key":"10.1016\/j.neuroscience.2026.02.023_b0015","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2026.02.023_b0020","article-title":"Lecanemab, aducanumab, and gantenerumab - binding profiles to different forms of amyloid-beta might explain efficacy and side effects in clinical trials for Alzheimer's disease","author":"Soderberg","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.neuroscience.2026.02.023_b0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11910-021-01125-y","article-title":"Critical appraisal of amyloid lowering agents in AD","volume":"21","author":"Decourt","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.023_b0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-017-0297-z","article-title":"Alzheimer's disease prevention: from risk factors to early intervention","volume":"9","author":"Crous-Bou","year":"2017","journal-title":"Alzheimers Res. Ther."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.023_b0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jalz.2012.12.004","article-title":"Can we prevent Alzheimer's disease? Secondary \u201cprevention\u201d trials in Alzheimer's disease","volume":"9","author":"Carrillo","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2026.02.023_b0040","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-221091","article-title":"Early detection of Alzheimer's disease-related pathology using a multi-disease diagnostic platform employing autoantibodies as blood-based biomarkers","author":"DeMarshall","year":"2023","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.023_b0045","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0006-291X(02)00384-4","article-title":"ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils","volume":"293","author":"Shiohara","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.02.023_b0050","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1074\/jbc.M113.505636","article-title":"Localization and functionality of the inflammasome in neutrophils","volume":"289","author":"Bakele","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"7685","key":"10.1016\/j.neuroscience.2026.02.023_b0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer's disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.neuroscience.2026.02.023_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134674","article-title":"The inflammasome adaptor protein ASC in mild cognitive impairment and Alzheimer's disease","volume":"21","author":"Scott","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"48","key":"10.1016\/j.neuroscience.2026.02.023_b0065","doi-asserted-by":"crossref","first-page":"33835","DOI":"10.1074\/jbc.274.48.33835","article-title":"ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells","volume":"274","author":"Masumoto","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.02.023_b0070","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00018-016-2396-6","article-title":"Assembly and regulation of ASC specks","volume":"74","author":"Hoss","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuroscience.2026.02.023_b0075","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2026.02.023_b0080","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41429-020-0282-9","article-title":"1-hydroxy-7-oxolavanducyanin and \u0394(7\u2033,8\u2033)-6\u2033-hydroxynaphthomevalin from Streptomyces sp. CPCC 203577","volume":"73","author":"Li","year":"2020","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.02.023_b0085","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s12264-022-00869-y","article-title":"Naturally-occurring antibodies against bim are decreased in Alzheimer's disease and attenuate AD-type pathology in a mouse model","volume":"38","author":"Jian","year":"2022","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.023_b0090","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13533","article-title":"Physiological clearance of Abeta by spleen and splenectomy aggravates Alzheimer-type pathogenesis","volume":"21","author":"Yu","year":"2022","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.023_b0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00401-018-1891-2","article-title":"Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies","volume":"136","author":"Wang","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.023_b0100","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41467-022-28986-2","article-title":"Lower novelty-related locus coeruleus function is associated with Abeta-related cognitive decline in clinically healthy individuals","volume":"13","author":"Prokopiou","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.023_b0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.023_b0110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","article-title":"The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy","volume":"126","author":"McGeer","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.023_b0115","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4103\/1673-5374.353484","article-title":"Targeting neuroinflammation in Alzheimer's disease: from mechanisms to clinical applications","volume":"18","author":"Si","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.023_b0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","article-title":"Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease","volume":"79","author":"Salloway","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuroscience.2026.02.023_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.805169","article-title":"Crosstalk between the NLRP3 inflammasome\/ASC speck and amyloid protein aggregates drives disease progression in alzheimer's and parkinson's disease","volume":"15","author":"Hulse","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.023_b0130","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00415-021-10790-5","article-title":"Alzheimer's disease clinical trial update 2019-2021","volume":"269","author":"Pleen","year":"2022","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.02.023_b0135","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/jcbfm.2009.46","article-title":"Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury","volume":"29","author":"de Rivero","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroscience.2026.02.023_b0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12974-016-0477-y","article-title":"Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease","volume":"13","author":"Couturier","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.023_b0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/imm.13375","article-title":"Unknown\/enigmatic functions of extracellular ASC","volume":"163","author":"de Souza","year":"2021","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.neuroscience.2026.02.023_b0150","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/ni.2913","article-title":"The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation","volume":"15","author":"Franklin","year":"2014","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.023_b0155","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","article-title":"Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo","volume":"137","author":"Stancu","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"7784","key":"10.1016\/j.neuroscience.2026.02.023_b0160","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2026.02.023_b0165","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","article-title":"Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes","volume":"156","author":"Lu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2026.02.023_b0170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuroscience.2026.02.023_b0175","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/sms.12584","article-title":"Forearm muscle activity is modified bilaterally in unilateral lateral epicondylalgia: A case-control study","volume":"26","author":"Heales","year":"2016","journal-title":"Scand. J. Med. Sci. Sports"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222600120X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222600120X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:47:24Z","timestamp":1777556844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645222600120X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":35,"alternative-id":["S030645222600120X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.02.023","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-ASC antibodies alleviate Alzheimer\u2019s disease\u2013type pathology in APP\/PS1 mice","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Brain Research Organization (IBRO).","name":"copyright","label":"Copyright"}]}}